Use access key #2 to skip to page content.
$10.27 -0.63 (-5.78%)
1/9/2009 4:00 PM

Alkermes, Inc. (ALKS)

CAPS Rating:
****

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

View All Commentary (ALKS)

Recs

0

Avatar RumbleDog (< 20) Submitted: 1/18/07 2:41 PM : Outperform Start Price: $14.94 ALKS Score: 6.21

Vivatrol will gain wider acceptance, Air inslulin will be approved and welcomed. New partners will come on board to diversify the company's stable.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links